News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
December, 2024
December 2024
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
3031  
Ghassan Abou-Alfa: ERBB2-altered gallbladder cancer characterization in Chile
genosciencepharma.com
Oct 9, 2024, 16:50

Ghassan Abou-Alfa: ERBB2-altered gallbladder cancer characterization in Chile

Ghassan Abou-Alfa, Medical Oncologist, Memorial Sloan Kettering Cancer Center, shared a post on X:

“Congratulations and thank you Sebastian Mondaca on superb valuable effort for Chile. Memorial Sloan Kettering Cancer Center, MSK Department of Medicine, Ghassan Abou-Alfa and team are proud for contributing to ERBB2-altered gallbladder cancer characterization in Chile!”

Clinical and genomic characterization of ERBB2-altered gallbladder cancer

Authors:  Sebastian Mondaca, Nikolaus Schultz, Juan Carlos Roa, Henry S. Walch, Santiago Sepulveda, James J.              Harding, Amin Yaqubie, Patricia Garcia, Gloria Aguayo, Bruno Nervi, Bob T. Li and  Ghassan K. Abou-Alfa.

Ghassan Abou-Alfa: ERBB2-altered gallbladder cancer characterization in Chile

Amin Yaqubie Bob T. Li Bruno Nervi cancer cancer awareness cancer care fight against cancer Ghassan Abou-Alfa Ghassan K. Abou-Alfa Global fight against cancer Gloria Aguayo Henry S. Walch James J. Harding JCO Journal of Clinical Oncology Juan Carlos Roa Memorial Sloan Kettering Cancer Center MSK Department of Medicine Nikolaus Schultz OncoDaily Oncology Patricia Garcia Santiago Sepulveda Sebastian Mondaca
Special Coverage
Career
Dec 21, 2024, 07:45
OncoInfluencers to Follow on Social Media: Dr. Liang Cheng
Insight
Dec 21, 2024, 07:31
Update on U.S. regulatory review of subcutaneous amivantamab for EGFR + lung cancer
Science
Dec 21, 2024, 07:05
Naseema Gangat: Practical prognostic tool for the current standard of care in older/unfit AML
Blog
Dec 21, 2024, 05:54
LCC in Spanish: LALCA 2024 Highlights
Blog
Dec 21, 2024, 05:50
The Opportunities Are Endless: CU Cancer Center leader Enrique Soto Pérez de Celis signs key international agreement
Insight
Dec 21, 2024, 05:42
Raffaella Casolino: How to integrate cancer into crisis?
Insight
Dec 21, 2024, 05:01
FDA Grants Dostarlimab Breakthrough Therapy Designation in dMMR/MSI-H Rectal Cancer
Blog
Dec 21, 2024, 05:01
Omolola Salako: A year ago, Pearl Oncology Specialist Hospital became a 24-hour, 10-bed cancer center
Science
Dec 21, 2024, 04:57
Alexandre Chan: Updates on repurposing riluzole as a treatment for cancer-related cognitive impairment
Blog
Dec 21, 2024, 04:55
Milan Mishkovikj: The Patient at the Center - Value-Based Healthcare in Oncology
Insight
Dec 21, 2024, 04:52
Do national cancer control plans address care and research for children and AYAs - SIOP
Insight
Dec 21, 2024, 04:36
A holistic global strategy for incorporating cancer care into crisis response initiatives - The Institute of Cancer and Crisis